Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: RIZATRIPTAN BENZOATE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078173
Product Number: 002
Approval Date: Dec 31, 2012
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information